Schilling, Marcel P.
El Khaled El Faraj, Razan
Urrutia Gómez, Joaquín Eduardo
Sonnentag, Steffen J.
Wang, Fei
Nestler, Britta
Orian-Rousseau, Véronique
Popova, Anna A.
Levkin, Pavel A.
Reischl, Markus
Funding for this research was provided by:
KIT Future Fields II (Screening Platform for Personalized Oncology (SPPO))
Karlsruher Institut für Technologie (KIT)
Article History
Received: 22 September 2022
Accepted: 23 March 2023
First Online: 29 March 2023
Competing interests
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Both A.A.P. and P.A.L. in addition to being employed by the KIT are also shareholders of Aquarray GmbH. Other co-authors declare no conflict of interests.